Arbutus Biopharma (ABUS) EBITDA Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
86,979.00 |
| Dec 31, 2025 |
36,167.00 |
| Sep 30, 2025 |
-21,926.00 |
| Jun 30, 2025 |
94,569.00 |
| Mar 31, 2025 |
-47,931.00 |
| Dec 31, 2024 |
72,543.00 |
| Sep 30, 2024 |
123,818.00 |
| Jun 30, 2024 |
243,513.00 |
| Mar 31, 2024 |
226,403.00 |
| Dec 31, 2023 |
9,855.00 |
| Sep 30, 2023 |
159,285.00 |
| Jun 30, 2023 |
136,176.00 |
| Mar 31, 2023 |
100,819.00 |
| Dec 31, 2022 |
201,023.00 |
| Sep 30, 2022 |
-13,186.00 |
| Jun 30, 2022 |
172,465.00 |
| Mar 31, 2022 |
751,086.00 |
| Dec 31, 2021 |
11.15 Mn |
| Sep 30, 2021 |
195,713.00 |
| Jun 30, 2021 |
4.12 Mn |
